Delving into the Latest Updates on 台湾A2医疗保健股份有限公司 with Synapse

概览

关联

9

项与台湾A2医疗保健股份有限公司相关的临床试验

NCT05027581 / Active, not recruiting临床2期

A Phase IIb Study to Evaluate the Efficacy and Safety of Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

This is a randomized, single-blind, parallel, active-controlled study to evaluate the efficacy and safety of bone marrow mesenchymal stem cells (BM-MSCs), Chondrochymal®, in subjects aged 40 to 80 with knee OA.

开始日期2021-09-15

申办/合作机构

台寶生醫股份有限公司

[+1]

NCT02289300 / Withdrawn临床2期

A Phase II Randomized, Double-Blind, Placebo Controlled, Parallel Study of DCB-BO1202 for Alleviating Liver Fibrosis in HBV Patients With Intermediate Hepatocellular Carcinoma Receiving Loco-regional Therapies

The purpose of this study is to determine whether an investigational drug DCB-BO1202 is effective and safe in the treatment of liver fibrosis in HBV patients having experienced intermediate stage hepatocellular carcinoma (HCC)

开始日期2020-01-01

申办/合作机构

台湾A2医疗保健股份有限公司

[+1]

NCT03351322 / Completed临床2期

A Randomized, Double-Blind, Active-controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of ENERGI-F701 Solution in Female Subjects With Hair Loss

The objective of this study is to evaluate the efficacy and safety of ENERGI-F701 Solution in female subjects with hair loss.

开始日期2018-05-23

申办/合作机构